Tissue Analytics for In Vitro Diagnostics

Lunaphore Technologies specializes in advancing spatial biology through its innovative COMET™ platform, which offers a fully automated, high-throughput solution for multiplex imaging and analysis of biological samples. This platform allows researchers to perform spatial multiomics, enabling the simultaneous detection of RNA and protein targets on the same tissue section. By utilizing off-the-shelf, label-free primary antibodies, COMET™ simplifies the panel development process, allowing for rapid and flexible assay creation without the need for complex conjugation steps. The system is designed to maximize reproducibility and tissue preservation, making it suitable for a wide range of applications in immunology, oncology, and neuroscience.

The COMET™ platform is particularly notable for its scalability and efficiency, capable of processing multiple samples in a single run while maintaining high-quality imaging and data integrity. It integrates various steps of the workflow, including staining, imaging, and image preprocessing, into a seamless automated process. This capability not only enhances the understanding of cellular dynamics and disease mechanisms but also supports the identification of clinically relevant biomarker signatures. Lunaphore's commitment to making spatial biology accessible and efficient positions it as a key player in the field, facilitating advancements in research and clinical applications.

Switzerland

Lunaphore Technologies S.A., a Bio-Techne brand, is a Swiss-based life sciences company founded in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies.

Lunaphore Technologies

Company Details